Gene: ZFTA
Official Full Name: zinc finger translocation associatedprovided by HGNC
Gene Summary: Predicted to be involved in negative regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12378 | ZFTA Knockout cell line (HeLa) | Human | ZFTA | 1:3~1:6 | Negative | Online Inquiry |
KO12379 | ZFTA Knockout cell line (HCT 116) | Human | ZFTA | 1:2~1:4 | Negative | Online Inquiry |
KO12380 | ZFTA Knockout cell line (HEK293) | Human | ZFTA | 1:3~1:6 | Negative | Online Inquiry |
KO12381 | ZFTA Knockout cell line (A549) | Human | ZFTA | 1:3~1:4 | Negative | Online Inquiry |
ZFTA Gene Knockout Cell Lines represent a groundbreaking tool for the field of molecular biology and genetic research. These specialized cell lines have been engineered to lack the function of the ZFTA gene, which has been implicated in various cellular processes, including cell division and differentiation, making them invaluable for studying gene function and pathogenic mechanisms. By utilizing CRISPR-Cas9 technology, our ZFTA knockout cell lines are precisely designed to enable researchers to observe the consequences of ZFTA gene loss, facilitating the dissection of its roles in health and disease.
The primary function of the ZFTA Gene Knockout Cell Lines lies in their ability to serve as a controlled environment for experimentation. Researchers can use these cell lines to investigate the downstream effects of ZFTA gene disruption, including alterations in signaling pathways, gene expression patterns, and cellular behavior. This insight into the gene's function is crucial for understanding diseases, particularly certain cancers, where ZFTA mutations can lead to abnormal cell growth.
In both research and clinical settings, ZFTA knockout cell lines hold significant importance for applications such as drug discovery, biomarker identification, and therapeutic development. By studying these cells, scientists can identify potential targets for intervention, paving the way for novel treatments and improved patient outcomes.
Compared to alternative models, our ZFTA Gene Knockout Cell Lines offer superior specificity and reliability. They are rigorously validated to ensure that the knockout is complete, allowing for consistent results across experiments. This reliability reduces variability often seen with other knockout techniques, providing researchers with the confidence needed to draw meaningful conclusions from their data.
For researchers and clinicians focused on genetic studies, these cell lines represent a quintessential resource, enhancing experimental design and efficiency. By integrating ZFTA knockout models into their research, users can unlock new discoveries that could lead to transformative advancements in understanding and managing complex diseases.
Our company stands at the forefront of innovative biological products, with a strong commitment to providing high-quality research tools. With extensive expertise in genetic engineering and cell line development, we ensure that our ZFTA Gene Knockout Cell Lines are not only cutting-edge but also tailored to meet the needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.